BMC Infectious Diseases is calling for submissions to our Collection on Tropical vector-borne infectious diseases.

Tropical vector-borne infectious diseases represent a major global health challenge, particularly in low- and middle-income countries. Transmitted by vectors such as mosquitoes, ticks, and flies, these diseases include well-known conditions like malaria, dengue fever, and leishmaniasis, as well as neglected tropical diseases. Their transmission dynamics are shaped by a complex interplay of environmental, climatic, social, and behavioral factors, making integrated and interdisciplinary research essential for effective control and prevention.

Addressing these diseases is vital not only for the health of affected populations but also for global health security. Recent advances in surveillance, vector control, therapeutics, and vaccines have improved our ability to respond to outbreaks. However, continued research is needed to understand the mechanisms of disease transmission, predict emerging threats, and implement effective interventions in diverse tropical settings.

This Collection welcomes original research articles on, but not limited to, the following topics:

• Mechanisms of disease transmission in tropical environments
• Mechanisms of vector-borne disease transmission and vector-parasite-host interactions.
• Emerging tropical pathogens and their impact on human and animal health
• Surveillance strategies, including genomic, climate-informed, and digital approaches
• Vector control strategies and evaluation of their effectiveness
• Epidemiological and mathematical modeling of vector-borne diseases
• One Health approaches linking humans, animals, and the environment

We encourage interdisciplinary submissions that advance understanding of vector-borne disease dynamics and support the development of innovative, data-driven strategies for disease prevention, control, and global health resilience.

This Collection supports and amplifies research related to SDG 3 (Good Health and Well-being).

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

BMC Infectious Diseases invites submissions for a Collection on Tuberculosis and co-infections: diagnostics, management, and treatment.

Tuberculosis (TB) remains a leading cause of morbidity and mortality worldwide, particularly in regions with high prevalence rates and co-infections. The interplay between TB and various co-infections (including bacterial, viral, parasitic and fungal), complicates diagnosis and treatment strategies. Advances in molecular diagnostics and imaging techniques have improved our understanding of how these co-morbidities affect TB pathogenesis and treatment outcomes. However, the challenge of managing drug-resistant TB adds an additional layer of complexity, necessitating a comprehensive approach that integrates the latest research findings with clinical practice.

Research into TB of all stages and its co-infections is crucial for addressing the rising incidence of drug resistance and improving patient outcomes. Recent studies have identified critical biomarkers for early detection and prognosis, highlighting the role of rapid diagnostic tools in the clinical setting. Additionally, understanding the mechanisms of co-infections has led to tailored treatment regimens that maximize efficacy while minimizing adverse effects. Nonetheless, gaps remain in our knowledge of optimal management strategies for these complex cases, emphasizing the need for ongoing research in this field.

Future research endeavors should focus on the development of more effective diagnostic techniques and treatment protocols that consider the multifaceted interactions between TB and its co-infections. Innovations in personalized medicine may lead to targeted therapies that address specific pathogen interactions, ultimately enhancing patient recovery rates. Moreover, collaborative efforts between public health entities and research organizations could pave the way for comprehensive TB surveillance systems, fostering the identification of emerging trends in co-infection patterns.

This Collection welcomes original research articles on topics including but not limited to:

• Diagnostic innovations for Tuberculosis and co-infections
• Management strategies for drug-resistant Tuberculosis
• Interaction between Tuberculosis and HIV
• Tuberculosis and diabetes comorbidity
• Tuberculosis in the context of viral hepatitis and COVID-19

This Collection supports and amplifies research related to SDG 3 (Good Health and Well-being).

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.